Abbott Laboratories (ABT) Financials

ABT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 ? ?
March 31, 2026 110.4 billion 57.7 billion
Dec. 31, 2025 86.7 billion 33.9 billion
Sept. 30, 2025 84.2 billion 32.9 billion

ABT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 ? ?
March 31, 2026 916.0 million 317.0 million
Dec. 31, 2025 2.6 billion 113.0 million
Sept. 30, 2025 2.3 billion 120.0 million

ABT Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 ?
March 31, 2026 1.1 billion
Dec. 31, 2025 1.8 billion
Sept. 30, 2025 1.6 billion

ABT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 - - -
March 31, 2026 7.3 billion 29.6 billion -
Dec. 31, 2025 8.9 billion 10.8 billion 931.0 million
Sept. 30, 2025 7.7 billion 11.6 billion -

ABT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 1.7 billion
March 31, 2026 1.7 billion
Dec. 31, 2025 1.7 billion
Sept. 30, 2025 1.7 billion

ABT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 882.0 million 4.0 billion -
March 31, 2026 399.0 million 756.0 million 3.3 billion -
Dec. 31, 2025 689.0 million 735.0 million 3.1 billion -
Sept. 30, 2025 496.0 million 785.0 million 3.1 billion -

ABT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 12.6 billion 5.3 billion
March 31, 2026 11.2 billion 4.9 billion
Dec. 31, 2025 11.5 billion 4.9 billion
Sept. 30, 2025 11.4 billion 5.0 billion

ABT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ABT

Price: $116.66

52 week price:
81.97
137.49

Dividend Yield: 2.36%

5-year range yield:
1.48%
2.84%

Forward Dividend Yield: 2.16%

Payout Ratio: 69.40%

Payout Ratio Range:
-129.15%
247.91%

Dividend Per Share: 2.52 USD

Earnings Per Share: 3.12 USD

P/E Ratio: 32.23

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 5.1 million

Ebitda: 1.7 billion

Market Capitalization: 181.6 billion

Average Dividend Frequency: 4

Years Paying Dividends: 44

DGR3: 7.64%

DGR5: 10.77%

DGR10: 9.57%

DGR20: 8.39%

Links: